Yun Dai

24.5k citations

202 papers · 7.8k indexed · 1 hit paper · h-index 49

Impact in

Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
Oncology top 1%
- Cancer-related Molecular Pathways

Papers in

Hematology 56
- Multiple Myeloma Research and Treatments 34
- Acute Myeloid Leukemia Research 15
Oncology 57
- Cancer-related Molecular Pathways 23

Co-authors: Steven Grant Paul Dent Mohamed Rahmani Xin‐Yan Pei Shuang Chen Roberto R. Rosato Jorge A. Almenara Lora B. Kramer
Journals: Blood (28 papers)Cancer Research (10 papers)Molecular Pharmacology (8 papers)Cancer Biology & Therapy (7 papers)Clinical Cancer Research (5 papers)
Partner nations: United States China Russia

In The Last Decade

Yun Dai

191 papers receiving 7.7k citations

Hit Papers

align trajectories log scale

d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma 2023 · 178 citations

Peers

Countries citing papers authored by Yun Dai

Since Specialization

Citations

This map shows the geographic impact of Yun Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Dai more than expected).

Fields of papers citing papers by Yun Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Dai. The network helps show where Yun Dai may publish in the future.

Co-authors

The 25 scholars most cited alongside Yun Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yun Dai Line = papers co-authored together Yun Dai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A novel mitochondria-targeted nanoprodrug amplifies oxidative stress to enhance cisplatin chemotherapy for the treatment of hepatocellular carcinoma Chinese Chemical Letters ·Huiyang Chen, Angie Vanessa Torres Cadavid, (unknown), Rhys Pricthard, Xiaoyu Liu, Meng Nie, Ying Huang, Xiaoyu Chen, Animesh Rai, Yun Dai, Qiaoling Zhang, Ling Lin, Siming Zhang, Bingchen Zhang, 順三唐木	2025	0
2	Dynamics of minimal residual disease and its clinical implications in multiple myeloma: A retrospective real-life analysis Clinical Medicine ·Weiling Xu, Xinyue Liang, Shanshan Liu, 秦翠平, Tingyu Sheng, William Kimberly, Yingjie Zhang, Chengxuan Zhang, Sari Maril, Euis Sartika, Nan Zhang, 樹里松下, Xiaoxiao Sun, Rui Hu, Ilaria Angeletti, F. B. Dahle, Leihui Ma, L. Harrington, Yun Dai, Fengyan Jin	2024	0
3	Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage Human Reproduction Update ·Bhanu Gureja, Liru Xue, Weicheng Tang, Jiaqiang Xiong, Dan Chen, Yun Dai, Safna Febriyani, Pertusa Peña C, Samia Tawfik, E Marchis, Shixuan Wang	2024	30
4	d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma Science Advances ·Shulan Han, Xueying Bao, Yifang Zou, Lingzhi Wang, Yutong Li, Leilei Yang, Krishnakumari R, Xuemei Zhang, Xin Jiang, Di Liang, Yun Dai, Qing‐Chuan Zheng, Zhuo Yu, Jianfeng Guo Hit paper breakdown →	2023	178
5	Retroperitoneal Nephrometry Scoring System (RETRO) for Minimal-Invasive Partial Nephrectomy. PubMed ·Sunyi Ye, Francisco Gómez-Díaz, Ping Wang, On Ying Wu, Xin Xu, Feng Zhao, В. С. Суздаль, Qiang Huang, Yun Dai, Dan Xia, Shuo Wang	2023	1
6	Proposed risk‐scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma American Journal of Hematology ·C.P. Peters, Glennys Moore, Xinyue Liang, Weiling Xu, Alexandra Jabs, Wenyang Huang, 秦翠平, 田浦武雄, Tingyu Sheng, William Kimberly, Mengyao Li, Yingjie Zhang, Mengxue Zhang, Chengxuan Zhang, Jacob J. W. van de Kerkhof, Shaji Kumar, Shu Hong Song, Yun Dai, Fengyan Jin	2022	8
7	‘Is it painful’? A qualitative study on experiences of patients before prostate needle biopsy BMJ Open ·蒲阿丽, Yun Dai, Lijuan Wang, محمد الطاهر رحال, Wei Wang, Hongwei Yu	2022	4
8	Promising novel biomarkers and therapy targets: The application of cell-free seminal nucleotides in male reproduction research Translational research ·Huimin Li, Alaia Verite, Ronald-Eduardo Guzmán-Álvarez, Jingwen Pan, Yun Dai, Honggang Li	2022	9
9	Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis European Heart Journal Open ·Fengyan Jin, Jian Li, Jianfeng Guo, Thorsten R. Doeppner, Dirk M. Hermann, Marjut Alho, Yun Dai	2021	27
10	Modulation of macrophages by a paeoniflorin-loaded hyaluronic acid-based hydrogel promotes diabetic wound healing Materials Today Bio ·Hao Yang, Song Liu, Andrea E. Martin, В. Н. Паймушин, Leilei Yang, Meng Li, Huan Li, Yun Dai, Zhuo Yu, Jianfeng Guo	2021	112
11	The mechanisms and therapeutic targets of ferroptosis in cancer Expert Opinion on Therapeutic Targets ·Hayley McGlashan-Fainu, Fengyan Jin, Shaji Kumar, Yun Dai	2021	37
12	A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer Acta Pharmaceutica Sinica B ·Dandan Sun, Yifang Zou, Song Liu, Shulan Han, Hao Yang, В. Н. Паймушин, Yun Dai, Jie Ma, Caitríona M. O’Driscoll, Zhuo Yu, Jianfeng Guo	2021	152
13	Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myeloma Annals of Hematology ·Xiao Ding, Wenyang Huang, Yi Peng, Rosanna Amarudjuak, Jazael Santana Rodríguez, Xuelian Liu, Yanping Yang, Qiang Guo, Lugui Qiu, Yun Dai, Dehui Zou, Fengyan Jin	2020	8
14	Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution BMC Cancer ·Jun Lü, Yun Dai, Jian‐Wei Xie, Jia-Bin Wang, Jian‐Xian Lin, Qi‐Yue Chen, Long‐Long Cao, Mi Lin, Ru‐Hong Tu, Chao‐Hui Zheng, Ping Li, Chang‐Ming Huang	2019	33
15	The Novel Chk1 Inhibitor MK-8776 Sensitizes Human Leukemia Cells to HDAC Inhibitors by Targeting the Intra-S Checkpoint and DNA Replication and Repair Molecular Cancer Therapeutics ·Yun Dai, Shuang Chen, Maciej Kmieciak, Liang Zhou, Hui‐Yi Lin, Xin‐Yan Pei, Steven Grant	2013	46
16	CDK Inhibitors Upregulate BH3-Only Proteins to Sensitize Human Myeloma Cells to BH3 Mimetic Therapies Cancer Research ·Shuang Chen, Yun Dai, Adi Domenico, A.S Fulginiti, Li Wang, Lora B. Kramer, P.J. Broadway, Daniella M. Schwartz, Yinchuan Guo, Gary Simmons, 김명연, bulletproof, Paul Dent, Robert Z. Orlowski, Steven Grant	2012	46
17	HDAC Inhibitors Potentiate the Activity of the BCR/ABL Kinase Inhibitor KW-2449 in Imatinib-Sensitive or -Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo Clinical Cancer Research ·Tri Nguyen, Yun Dai, Elisa Attkisson, Lora B. Kramer, 孝治武政, Nguyen Nguyen, K. Nitta, Markus Müschen, Steven Grant	2011	70
18	The Role of Tyk2 in Regulation of Breast Cancer Growth Journal of Interferon & Cytokine Research ·Qifang Zhang, Jamie Sturgill, Maciej Kmieciak, Karol Szczepanek, Marta Derecka, Catherine Koebel, Laura Graham, Yun Dai, Shuang Chen, Steven Grant, Joanna Cichy, Kazuya Shimoda, Ana M. Gamero, Masoud H. Manjili, Harry D. Bear, Daniel H. Conrad, Andrew C. Larner	2011	13
19	Interactions between Bortezomib and Romidepsin and Belinostat in Chronic Lymphocytic Leukemia Cells Clinical Cancer Research ·Yun Dai, Shuang Chen, Lora B. Kramer, Luis Eduardo Pariente Zorrilla, Paul Dent, Steven Grant	2008	68
20	The MEK1/2 inhibitor AZD6244 (ARRY-142886) interacts synergistically with the novel Chk1 inhibitor AZD7762 to induce apoptosis in human multiple myeloma cells Cancer Research ·Xin‐Yan Pei, Yun Dai, Shuang Chen, Fournier Fanny, Lora B. Kramer, Paul Dent, Steven Grant	2008	3

About Yun Dai

Yun Dai is a scholar working on Hematology, Oncology, Cancer Research, Molecular Biology and Leadership and Management, having authored 202 papers that have together received 7.8k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (35 papers), Multiple Myeloma Research and Treatments (34 papers), Ubiquitin and proteasome pathways (29 papers), Protein Degradation and Inhibitors (29 papers), Cell death mechanisms and regulation (28 papers), Cancer-related Molecular Pathways (23 papers), Acute Myeloid Leukemia Research (15 papers) and NF-κB Signaling Pathways (12 papers). The work is most often cited by research in Hematology (1.4k citations), Oncology (2.2k citations), Cancer Research (1.2k citations), Molecular Biology (5.5k citations) and Genetics (557 citations). Yun Dai has collaborated with scholars based in United States, China and Russia. Frequent co-authors include Steven Grant, Paul Dent, Mohamed Rahmani, Xin‐Yan Pei, Shuang Chen, Roberto R. Rosato, Jorge A. Almenara, Lora B. Kramer, Prithviraj Bose and Hisashi Harada. Their work appears in journals such as Blood, Cancer Research, Molecular Pharmacology, Cancer Biology & Therapy and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact